Skip to main content


Clinical Research

Current clinical trials at site:

  • NATRON (D3254C00001) / Indication: Hypereosinophilic Syndrome (HES) / Sponsor: AstraZeneca
  • ROR-PH-301 (Advance OUTCOMES) / Indication: Pulmonary Arterial Hypertension (PAH) / Sponsor: United Therapeutics
  • EXPOSURE / Indikation: Pulmonary Arterial Hypertension (PAH) / Sponsor: Actelion Pharmaceuticals Ltd. (Part of Janssen Pharmaceuticals – J&J)
  • ASCENT (D5180R00011) / Indication: Severe Asthma / Sponsor: AstraZeneca

Further upcoming:

  • COPD Trial
  • PH-ILD Trial

Biomedical research:

  • REASSESS: Rheumatoid Arthritis and pleuropulmonary disease screening